関連する実験動画
Updated: Sep 9, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
炎症性腸疾患におけるライフスタイルと心理的要因:流行,影響,動機付け,支援の必要性
Karlijn Demers1,2,3, Evelien M B Hendrix1,3, Ashkan Rezazadeh Ardabili1,3
1Department of Gastroenterology and Hepatology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
PloS one
|August 29, 2025
まとめ
炎症性腸疾患 (IBD) の患者は,しばしば不適切な生活様式と心理社会的要因を経験し,その症状への影響を認識し,変化を望む. しかし 病院 の 支援 が 十分 に ない 場合 も 少なく あり ます.
科学分野:
- 胃腸内科
- 公衆衛生
- 心理学
背景:
- ライフスタイルと心理的要因は,炎症性腸疾患 (IBD) の粘膜炎と患者の健康状態に大きく影響します.
- 現在のIBDのケアでは ライフスタイルや心理的社会要素の 体系的な評価や介入が欠けていることが多いのです
研究 の 目的:
- IBD患者における不利なライフスタイルと心理的社会的要因の流行を推定する.
- IBD患者の視点と 病への影響について
主な方法:
- 多中心研究では,遠隔医療プラットフォームを使用して,IBD患者の疾患活動,ライフスタイル,および心理社会的要因に関するデータを収集しました.
- オランダのIBD患者団体が 実施した全国的なオンライン調査で 患者の視点が捉えられました
主要な成果:
- IBD患者の大部分は不十分な運動,喫煙,過剰なアルコール摂取を報告しました.
- 多くの患者は高いストレス,睡眠不足,感情的苦痛を経験し,これらの要因が腸の症状を悪化させると信じていました.
- 患者の約20%は変化を望むが,生活様式や心理的社会問題に対する病院のサポートを受けなかった.
結論:
- IBD患者は通常,有害な生活様式や心理的社会要因に直面し,その症状への影響を認識しています.
- ライフスタイルや心理的社会的な要因を改変する強い患者の動機づけがあり, 標的を絞った介入の必要性を強調しています.
- IBDのケアに ライフスタイルと心理的支援を体系的に統合することは 患者中心の管理に不可欠です
さらに関連する動画
関連する概念動画
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
Inflammatory Bowel Disease II: Crohn's Disease
375
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
375
Irritable Bowel Syndrome I: Introduction
369
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
369
Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185

